Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration

Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration

Background: Autoimmune hepatitis (AIH) is a chronic autoimmune inflammatory disease that usually requires lifelong immunosuppression. Frequent recurrences after the discontinuation of therapy indicate that intrahepatic immune regulation is not restored by current treatments. Studies of other autoimm...

Full description

Bibliographic Details
Main Authors: Laura Elisa Buitrago-Molina, Janine Dywicki, Fatih Noyan, Lena Schepergerdes, Julia Pietrek, Maren Lieber, Jerome Schlue, Michael P. Manns, Heiner Wedemeyer, Elmar Jaeckel, Matthias Hardtke-Wolenski
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cells
Subjects:
autoimmune hepatitis
anti-CD20 therapy
immune tolerance
regeneration
hepatic inflammation
Online Access:https://www.mdpi.com/2073-4409/10/6/1471

Internet

https://www.mdpi.com/2073-4409/10/6/1471

Similar Items